S95021, a novel selective and pan-neutralizing anti interferon alpha (IFN-α) monoclonal antibody as a candidate treatment for selected autoimmune rheumatic diseases

por Duguet, Fanny, Ortega-Ferreira, Céline, Fould, Benjamin, Darville, Hélène, Berger, Sylvie, Chomel, Agnès, Leclerc, Grégory, Kisand, Kai, Haljasmägi, Liis, Hayday, Adrian C., Desvaux, Emiko, Nony, Emmanuel, Moingeon, Philippe, De Ceuninck, Frédéric
Publicado 2021